These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 16705063

  • 1. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.
    Iizuka K, Miller B, Uyeda K.
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E358-64. PubMed ID: 16705063
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of ChREBP in hepatic steatosis and insulin resistance.
    Denechaud PD, Dentin R, Girard J, Postic C.
    FEBS Lett; 2008 Jan 09; 582(1):68-73. PubMed ID: 17716660
    [Abstract] [Full Text] [Related]

  • 8. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
    Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B, Reitman ML, Gonzalez FJ.
    J Clin Invest; 2003 Mar 09; 111(5):737-47. PubMed ID: 12618528
    [Abstract] [Full Text] [Related]

  • 9. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
    Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H.
    Hepatology; 2003 Dec 09; 38(6):1529-39. PubMed ID: 14647064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice.
    Leclercq IA, Field J, Enriquez A, Farrell GC, Robertson GR.
    Biochem Biophys Res Commun; 2000 Feb 16; 268(2):337-44. PubMed ID: 10679205
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
    Hsu SC, Huang CJ.
    J Nutr Biochem; 2007 Feb 16; 18(2):86-96. PubMed ID: 16713235
    [Abstract] [Full Text] [Related]

  • 18. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
    Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, Martines D.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb 16; 292(2):G518-25. PubMed ID: 17023554
    [Abstract] [Full Text] [Related]

  • 19. AMP-activated protein kinase and carbohydrate response element binding protein: a study of two potential regulatory factors in the hepatic lipogenic program of broiler chickens.
    Proszkowiec-Weglarz M, Richards MP, Humphrey BD, Rosebrough RW, McMurtry JP.
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Sep 16; 154(1):68-79. PubMed ID: 19427916
    [Abstract] [Full Text] [Related]

  • 20. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX, Murray SF, Watts L, Booten SL, Tokorcheck J, Monia BP, Bhanot S.
    Am J Physiol Endocrinol Metab; 2008 Aug 16; 295(2):E436-45. PubMed ID: 18523126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.